#FORTEStudy in Chicago!

October 12 2022

NRG-CC005 at the NRG Summer Meeting

The NRG Summer Meeting was held in-person in Chicago on July 21-23, 2022 (July 18-25 virtually), where the FORTE study was presented by NRG Oncology staff and study leadership. At the Protocol Support Committee (PSC) Continuing Education Session on Thursday, FORTE patient-directed materials were discussed in detail to highlight the ways site staff can use them both in enrollment efforts and to maintain contact with study participants between follow-up timepoints. In particular, the patient letter is a useful tool to reach out to potentially eligible participants as part of screening efforts at a site.

The FORTE Workshop was held on Friday, where Study Chair, Dr. Robert Schoen, reviewed why the FORTE trial is a national priority. Additional topics discussed included establishing partnerships with gastroenterology practices to enroll patients (Dr. Jeffrey Dueker, Protocol Co-Chair), how FORTE operates at Metro-MN Community Oncology Research Consortium (Jodi Geer, Senior Cancer Control Specialist at Metro-Minnesota Community Oncology Research Consortium), social media activity (Cheryl Leow, FORTE Education and Communication Specialist), and data management (Izabela Frak, FORTE Data Manager). The team also answered questions about NRG-CC005 after the presentations. Watch the FORTE Workshop recording to review these topics and more.

We encourage site staff to reach out to forte@nrgoncology.org with suggestions on materials NRG staff can create to assist you with participant enrollment and retention.

Accrual Updates and Milestones (as of September 30, 2022)

Top accruing sites:

  • Kaiser Permanente – Vallejo – 78 accrued
  • UPMC-Presbyterian Hospital – 53 accrued
  • Park Nicollet Clinic – Saint Louis Park – 46 accrued

Most recent randomizations:

  • Kaiser Permanente – Vallejo – September 28, 2022
  • UPMC-Presbyterian Hospital – September 28, 2022
  • Park Nicollet Clinic – Saint Louis Park – September 28, 2022

Thanks to your recruitment efforts, FORTE has accrued over 175 participants in just a few months!

Encourage your sites to interact with #FORTEStudy on social media!

LinkedIn: https://www.linkedin.com/company/forte-study

Twitter: https://twitter.com/fortestudy

Facebook: https://www.facebook.com/FORTEStudy

Instagram: https://www.instagram.com/fortestudy/

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:

1(800) 477-7227

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.